Stages I-III Pancreatic Cancer

November Is National Pancreatic Cancer Awareness Month (11-5-2009)

As the month of November brings pancreatic cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated pancreatic... Continue Reading

Chemotherapy Improves Pancreatic Cancer Survival (09-9-2009)

Among patients with inoperable pancreatic cancer, Gemzar® (gemcitabine)-based chemotherapy results in longer survival and better quality of life than an alternative treatment regimen consisting of enzyme therapy, nutritional supplements, detoxification,... Continue Reading

Pancreatic Cancer Care Is Inconsistent (07-21-2009)

The quality of care for pancreatic cancer varies considerably among hospitals in the United States, according to the results of a study published in the Journal of the National Cancer Institute.[1] Pancreatic cancer has one of the highest mortality rates... Continue Reading

Neoadjuvant Radiation Improves Survival in Pancreatic Cancer (03-8-2009)

Neoadjuvant Radiation Improves Survival in Pancreatic Cancer Preoperative radiation nearly doubles the survival rate for patients with operable pancreatic cancer, according to the results of a study published in the November 15, 2008 issue of the International... Continue Reading

EndoTAG™-1 Shows Promise in Treatment of Pancreatic Cancer (03-8-2009)

EndoTAG™-1 Shows Promise in Treatment of Pancreatic Cancer According to the results of a Phase II clinical trial, the addition of the investigational drug EndoTAG™-1 to chemotherapy with Gemzar® (gemcitabine) may improve survival among patients with... Continue Reading

Gemzar® Improves Survival with Early Pancreatic Cancer (03-8-2009)

Gemzar® Improves Survival with Early Pancreatic Cancer Adjuvant (post-surgery) chemotherapy with Gemzar® (gemcitabine) significantly improves disease-free and overall survival among patients with early pancreatic cancer. These findings were presented... Continue Reading

Abraxane®/Gemzar® Promising in Pancreatic Cancer (03-8-2009)

Abraxane®/Gemzar® Promising in Pancreatic Cancer The chemotherapy combination consisting of Abraxane® (paclitaxel) and Gemzar® (gemcitabine) appears promising for the treatment of advanced pancreatic cancer. These results were recently presented at... Continue Reading

Addition of Gemzar® in Early Pancreatic Cancer May Modestly Improve Survival (03-8-2009)

Addition of Gemzar® in Early Pancreatic Cancer May Modestly Improve Survival The addition of Gemzar® (gemcitabine) to 5-fluorouracil may modestly improve survival among patients with early pancreatic cancer. Further study is necessary, however, to determine... Continue Reading

Levels of CA 19-9 Following Treatment Not Indicative of Survival in Pancreatic Cancer (03-8-2009)

Levels of CA 19-9 Following Treatment Not Indicative of Survival in Pancreatic Cancer Among patients with pancreatic cancer, levels of a specific component of certain carbohydrates (CA19-9) during and following treatment are not associated with survival... Continue Reading

Radiation Therapy May Be Effective in Early Pancreatic Cancer (03-8-2009)

Radiation Therapy May Be Effective in Early Pancreatic Cancer Radiation therapy may improve survival among patients diagnosed with early-stage pancreatic cancer. These findings were recently published in the journal Cancer. The pancreas is an organ surrounded... Continue Reading

« Previous PageNext Page »